Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.

作者: Ting Zhang , Zhiyuan Li , Ting Liu , Suxia Li , Hua Gao

DOI: 10.1371/JOURNAL.PONE.0196571

关键词:

摘要: Cyclosporine A (CsA) is an essential medication used to prevent corneal allograft rejection. Our preliminary studies revealed that CsA drug-delivery system (DDS) was more effective in preventing high-risk rejection than topical application. However, the impacts of DDS on intraocular immune microenvironment were not fully elucidated. In present study, we investigated effect cornea allograft, aqueous humor, and iris-ciliary body using a rabbit model penetrating keratoplasty. New Zealand white rabbits divided into four groups: normal control group, untreated eye drop group group. Graft survival monitored for 12 weeks, therapeutic effects evaluated at 3 weeks after mean graft time significantly prolonged when compared with groups. At all time-points, Langerhans cell density, inflammatory central thickness much lower(all p < 0.01) groups, which their parameters higher (all 0.01). Compared implanted markedly decreased CD11b+ CD8+ T infiltration grafts. treatment also greatly reduced CD4+ density expression interferon-gamma, interleukin-2 (IL-2), IL-6, CD80, CD86 mRNA both Moreover, IL-2 level humor (p Taken together, our results suggest anterior chamber create relative immunosuppressive graft, body, humor. Stabilizing could partially elucidate mechanism suppressing

参考文章(47)
Ting Liu, Min Chen, Fu-Hua Wang, Xin-Jie Zang, Wei-Yun Shi, Hua-Qing Gong, Lymphocyte infiltration and activation in iris-ciliary body and anterior chamber of mice in corneal allograft rejection. International Journal of Ophthalmology. ,vol. 5, pp. 681- 686 ,(2012) , 10.3980/J.ISSN.2222-3959.2012.06.06
Donald T.H. Tan, Prathiba Janardhanan, Huijun Zhou, Yiong-Huak Chan, Hla Myint Htoon, Leonard P.K. Ang, Laurence S. Lim, Penetrating keratoplasty in Asian eyes: the Singapore Corneal Transplant Study. Ophthalmology. ,vol. 115, pp. 975- 982 ,(2008) , 10.1016/J.OPHTHA.2007.08.049
Navid Ardjomand, D. Frank P. Larkin, D. Frank P. Larkin, Andrew J. T. George, Richard M. Comer, William J. King, Stefanos Theoharis, Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. Investigative Ophthalmology & Visual Science. ,vol. 43, pp. 1095- 1103 ,(2002)
Hongkui Zhang, Ling Wang, Longlu Zhang, Cyclosporine nanomicelle eye drop: a novel medication for corneal graft transplantation treatment. Biological & Pharmaceutical Bulletin. ,vol. 38, pp. 893- 900 ,(2015) , 10.1248/BPB.B15-00111
W.H. Beekhuis, M. Bartels, I.I.N. Doxiadis, G. van Rij, Degree of compatibility for HLA-A and -B affects outcome in high-risk corneal transplantation. Developments in ophthalmology. ,vol. 36, pp. 12- 21 ,(2003) , 10.1159/000067652
Pierre-Yves Mantel, Nadia Ouaked, Beate Rückert, Christian Karagiannidis, Roland Welz, Kurt Blaser, Carsten B. Schmidt-Weber, Molecular Mechanisms Underlying FOXP3 Induction in Human T Cells Journal of Immunology. ,vol. 176, pp. 3593- 3602 ,(2006) , 10.4049/JIMMUNOL.176.6.3593
Ulrike Heizmann, Thomas Reinhard, Philip Maier, Yvonne Kern, Daniel Böhringer, Predicting the risk for corneal graft rejection by aqueous humor analysis. Molecular Vision. ,vol. 17, pp. 1016- 1023 ,(2011)
Susan M. Nicholls, Sanjiv Banerjee, Francisco C. Figueiredo, Sara Crome, Sanjay Mistry, David L. Easty, Andrew D. Dick, Differences in leukocyte phenotype and interferon-gamma expression in stroma and endothelium during corneal graft rejection. Experimental Eye Research. ,vol. 83, pp. 339- 347 ,(2006) , 10.1016/J.EXER.2005.12.018
Hui Shao, Deming Sun, Sheher L Sun, Jose Maria Cruze, N Bora, Henry J Kaplan, None, Expression of B7 molecules in the eye during experimental Autoimmune Anterior Uveitis (EAAU) Current Eye Research. ,vol. 25, pp. 271- 277 ,(2002) , 10.1076/CEYR.25.5.271.13491
Simone Eperon, Marta Rodriguez-Aller, Konstantinos Balaskas, Robert Gurny, Yan Guex-Crosier, A new drug delivery system inhibits uveitis in an animal model after cataract surgery. International Journal of Pharmaceutics. ,vol. 443, pp. 254- 261 ,(2013) , 10.1016/J.IJPHARM.2012.12.033